GLP-1 receptor agonist

GLP-1 receptor agonist

Topic

Heard in 8 episodes across 7 shows since Aug 2026

GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 hormone to lower blood sugar levels, reduce appetite, and slow digestion. They are widely used in the treatment of type 2 diabetes and obesity, and are under study for other metabolic conditions. Common examples of this drug class include semaglutide, liraglutide, and tirzepatide.

Discussed inHealth & Science57%Politics29%Markets14%

Episodes

8
across 7 shows

This week

0
episodes on 0 shows

Expert statements

145
79 positive · 50 negative

Share of the conversation

Mentions of GLP-1 receptor agonist per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Sep 280.01‰1
Oct 240.01‰1
Nov 130.02‰2
Nov 150.02‰1
Nov 160.03‰1
Nov 200.03‰2

The full trend: rank, tone and why it is trending →

Email alert

Email me when GLP-1 receptor agonist comes up on a podcast

One email a week at most, with the new episodes that mention GLP-1 receptor agonist. Free, no account needed, unsubscribe in one click.

What experts have said about GLP-1 receptor agonist

145 statements · 79 positive · 50 negative · 7 mixed · 9 neutral

  1. Joe RoganPositiveNov 20, 2026· The Joe Rogan Experience

    Joe Rogan recommends GLP-1s for morbid obesity over remaining severely obese.

    “it's way better to lose all that weight and get on the GLP-1s than to be a guy who's like a day away. from a heart attack”

    Listen at 15:55

    Open the episode · #2584 - Mike Baker
  2. GLP-1 drugs work for severe childhood obesity.

    “The drugs work.”

    Listen at 10:35

    Open the episode · Did gold stop working, Anthropic’s IPO explained & Pimp my Portfolio with Luke Laretive
  3. Children may be more likely than adults to maintain GLP-1-related weight loss.

    “Maybe with kids, you, you know, because it is in that formative stage, maybe they have a better chance of sticking to it afterwards.”

    Listen at 12:15

    Open the episode · Did gold stop working, Anthropic’s IPO explained & Pimp my Portfolio with Luke Laretive

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

8 episodes featuring GLP-1 receptor agonist, newest first